Details of the Drug

General Information of Drug (ID: DMTAM2Q)

• Drug Name: LY-295501
• Synonyms: ILX-295501; N1-(3,4-Dichlorophenyl)-N2-(2,3-dihydrobenzofuran-5-ylsulfonyl)urea; 1-(3,4-Dichlorophenyl)-3-(2,3-dihydrobenzofuran-5-ylsulfonyl)urea

Indication

Disease Entry	ICD 11	Status	REF
Diabetic complication	5A2Y	Phase 2	[1]

• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C15H12Cl2N2O4S
  Canonical SMILES: C1COC2=C1C=C(C=C2)S(=O)(=O)NC(=O)NC3=CC(=C(C=C3)Cl)Cl
  InChI: 1S/C15H12Cl2N2O4S/c16-12-3-1-10(8-13(12)17)18-15(20)19-24(21,22)11-2-4-14-9(7-11)5-6-23-14/h1-4,7-8H,5-6H2,(H2,18,19,20)
  InChIKey: VAMFSFIPDOODFH-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 127737
  CAS Number: 150869-74-2
  UNII: 240Y4YO0TN
  DrugBank ID: DB12574
  TTD ID: D0BA8M

References

• [1] ClinicalTrials.gov (NCT00005645) ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment. U.S. National Institutes of Health.